NCT04834752View on ClinicalTrials.gov

Effect of H2 Receptor Antagonist and Proton Pump Inhibitor on the Positivity Rates and Clinical Outcomes of COVID-19

CompletedOBSERVATIONAL
Enrollment

400,000

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
COVID-19
Interventions
OTHER

No intervention (Retrospective Cohort Observational)

History of PPI and H2RA prescription of the participants who were tested for COVID-19 will be reviewed.

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

All Listed Sponsors
collaborator

Dong-A ST Co., Ltd.

INDUSTRY

lead

Seoul National University Hospital

OTHER